Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' was added and an older funding/operating status notice was removed; these are administrative changes and do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding notice at the top of the page and a new publication citation related to the study; removed an Erratum citation and updated the publication revision note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedGlossary display was added; Study Record Dates now include 'Last Update Submitted that Met QC Criteria', and the footer shows Revision: v3.4.0 with capitalization updated for 'No FEAR Act Data'. These changes are presentation and versioning updates and do not modify core study information or results.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated to v3.3.4, replacing the previous v3.3.3. This change is limited to internal version labeling and does not alter study details or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe CheckMate-032 publication citation in Publications From PubMed was updated: the erratum version is now listed, replacing the original citation.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's Locations section now adds multiple new study sites, including Alabama, Colorado, Connecticut, Florida, Georgia, Maryland, Massachusetts, Nebraska, New York, North Carolina, Oregon, Tennessee, Texas, Washington, Ontario, Uusimaa, Greater London, Lanarkshire, and Surrey. Several locations were removed, altering where the study is recruiting.SummaryDifference2%

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.